128 related articles for article (PubMed ID: 29963184)
1. Overexpression of the matrix metalloproteinase 11 gene is a potential biomarker for type 1 endometrial cancer.
Gómez-Macías GS; Garza-Rodríguez ML; Garza-Guajardo R; Monsiváis-Ovalle D; Ancer-Rodríguez J; Barrera-Saldaña HA; Barboza-Quintana O
Oncol Lett; 2018 Jul; 16(1):1073-1078. PubMed ID: 29963184
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma.
Iurlaro M; Loverro G; Vacca A; Cormio G; Ribatti D; Minischetti M; Ria R; Bruno M; Selvaggi L
Eur J Clin Invest; 1999 Sep; 29(9):793-801. PubMed ID: 10469168
[TBL] [Abstract][Full Text] [Related]
4. Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
Yang YH; Deng H; Li WM; Zhang QY; Hu XT; Xiao B; Zhu HH; Geng PL; Lu YY
Clin Cancer Res; 2008 Jan; 14(1):74-81. PubMed ID: 18172255
[TBL] [Abstract][Full Text] [Related]
5. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
6. Histopathological Prognostic Factors for Endometrial Carcinoma.
Florescu MM; Dragomirescu M; Stepan AE; Ciurea RN; Margaritescu C; Simionescu CE
Curr Health Sci J; 2016; 42(2):139-144. PubMed ID: 30568824
[TBL] [Abstract][Full Text] [Related]
7. Identification of Matrix Metalloproteinase 11 as a Prognostic Biomarker in Pancreatic Cancer.
Lee J; Lee J; Kim JH
Anticancer Res; 2019 Nov; 39(11):5963-5971. PubMed ID: 31704821
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
[TBL] [Abstract][Full Text] [Related]
9. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of MMP11 inhibits proliferation and invasion of gastric cancer cells.
Kou YB; Zhang SY; Zhao BL; Ding R; Liu H; Li S
Int J Immunopathol Pharmacol; 2013; 26(2):361-70. PubMed ID: 23755751
[TBL] [Abstract][Full Text] [Related]
11. Toll-Like Receptor 4 and Matrix Metalloproteases 11 and 13 as Predictors of Tumor Recurrence and Survival in Stage II Colorectal Cancer.
Eiro N; Carrión JF; Cid S; Andicoechea A; García-Muñiz JL; González LO; Vizoso FJ
Pathol Oncol Res; 2019 Oct; 25(4):1589-1597. PubMed ID: 30710321
[TBL] [Abstract][Full Text] [Related]
12. [Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma].
Guo W; Chen G; Zhu C; Wang H
Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):604-7. PubMed ID: 12487935
[TBL] [Abstract][Full Text] [Related]
13. Lentivirus-mediated RNA interference targeting the long noncoding RNA HOTAIR inhibits proliferation and invasion of endometrial carcinoma cells in vitro and in vivo.
Huang J; Ke P; Guo L; Wang W; Tan H; Liang Y; Yao S
Int J Gynecol Cancer; 2014 May; 24(4):635-42. PubMed ID: 24758900
[TBL] [Abstract][Full Text] [Related]
14. Lipocalin-2 and matrix metalloproteinase-9 expression in high-grade endometrial cancer and their prognostic value.
Srdelić Mihalj S; Kuzmić-Prusac I; Zekić-Tomaš S; Šamija-Projić I; Čapkun V
Histopathology; 2015 Aug; 67(2):206-15. PubMed ID: 25522256
[TBL] [Abstract][Full Text] [Related]
15. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
16. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
17. Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics.
Li CC; Hsieh MJ; Wang SS; Hung SC; Lin CY; Kuo CW; Yang SF; Chou YE
Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31940762
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of special AT-rich sequence-binding protein 1 in endometrial cancer: a clinicopathologic study.
Zhang Y; Wang L; Liu Y; Meng F; Wang S; Shang P; Gao Y; Chen X
Int J Gynecol Cancer; 2015 Jan; 25(1):4-11. PubMed ID: 25347096
[TBL] [Abstract][Full Text] [Related]
19. Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro.
Park DW; Ryu HS; Choi DS; Park YH; Chang KH; Min CK
Gynecol Oncol; 2001 Sep; 82(3):442-9. PubMed ID: 11520138
[TBL] [Abstract][Full Text] [Related]
20. Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor kappaB.
Oh JH; Kim JH; Ahn HJ; Yoon JH; Yoo SC; Choi DS; Lee IS; Ryu HS; Min CK
Gynecol Oncol; 2009 Sep; 114(3):509-15. PubMed ID: 19539355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
